Mon, May 9, 2022

Kyle Rose Upgraded (AXGN) to Strong Buy and Increased Target to $15 on, May 9th, 2022

Kyle Rose of Canaccord Genuity, Upgraded "AxoGen, Inc." (AXGN) to Strong Buy and Increased Target from $10 to $15 on, May 9th, 2022.

Kyle has made no other calls on AXGN in the last 4 months.



There is 1 other peer that has a rating on AXGN. Out of the 1 peers that are also analyzing AXGN, 0 agree with Kyle's Rating of Hold.



This is the rating of the analyst that currently disagrees with Kyle


  • Danielle Antalffy of "SVB Leerink" Maintained at Buy with Increased Target to $14 on, Thursday, May 5th, 2022